Ventyx biosciences to report first quarter 2022 financial results on may 12, 2022

Encinitas, calif., may 05, 2022 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx), (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that it will report financial results for the first quarter ended march 31, 2022 after market close on may 12, 2022. company management will host a conference call and webcast beginning at 4:30 p.m. et/ 1:30 p.m. pt that day to discuss the financial results and highlight recent pipeline and business progress.
VTYX Ratings Summary
VTYX Quant Ranking